• Contact
  • Svenska
Genomic Medicine Sweden
  • Disease areas
    • Childhood cancer
    • Complex diseases
    • Hematology
    • Infectious diseases
    • Pharmacogenomics
    • Rare diseases
    • Solid tumours
  • Collaboration
    • Academia and infrastructures
    • Clinical studies
    • Healthcare providers and authorities
    • Industry
    • International
    • Patient organizations
    • SciLifeLab
  • IT-Informatics
    • IT – Informatics
    • Bioinformatics Analysis Tools
    • National Genomics Platform
    • Development projects and pilot studies
  • News
  • About us
    • About us
    • Organisation & governance
Select Page
Paediatricians in Sweden propose whole genome sequencing as a routine diagnostic test for all childhood cancer patients

Paediatricians in Sweden propose whole genome sequencing as a routine diagnostic test for all childhood cancer patients

7 November, 2023 | News

The Swedish Paediatric Association’s Section for Paediatric Haematology and Oncology recommends that whole genome sequencing should be a clinical routine at diagnosis for all childhood cancer patients. “For GMS Childhood Cancer, the statement is a...
Genomic Medicine Sweden awarded SEK 30 million for national and international data sharing for precision medicine

Genomic Medicine Sweden awarded SEK 30 million for national and international data sharing for precision medicine

11 October, 2023 | News

The Swedish Innovation Agency Vinnova has decided to fund the further development and implementation of the National Genomics Platform so that data generated in healthcare can be put to the greatest possible use. For healthcare, research and innovation. “This is...
Mutation in lung cancer patients linked to increased risk of brain metastases

Mutation in lung cancer patients linked to increased risk of brain metastases

26 September, 2023 | Press release

A population-based study of 6,000 lung cancer patients shows that patients with the KRAS G12C mutation have a high risk of brain metastases. Surprisingly this is not linked to worse survival. The study was conducted by researchers affiliated with Genomic Medicine...
Using whole-genome sequencing in the diagnostics of acute lymphoblastic leukemia in children

Using whole-genome sequencing in the diagnostics of acute lymphoblastic leukemia in children

21 August, 2023 | News

A new Swedish study shows that whole genome sequencing can detect clinically relevant genomic abnormalities in acute lymphoblastic leukemia, ALL, and has great potential to be implemented in the diagnostic setting. The study, conducted by researchers within the GMS...
Whole genome sequencing provides important information for treating children with cancer

Whole genome sequencing provides important information for treating children with cancer

10 July, 2023 | News

Results from the first 117 children to receive whole genome sequencing through the national GMS Childhood Cancer project show that in 90% of cases, genetic changes of clinical significance were found. The extensive work was carried out by more than 30 researchers and...
« Older Entries
More news in Swedish
Events in Swedish

Arkiv

  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
Genomic Medicine Sweden logo

Genomic Medicine Sweden
c/o Research and development Unit
Department for Healthcare Governance
298 89 Kristianstad
Sweden

  • About us
  • News
  • Contact

Genomic Medicine Sweden (GMS) is a national infrastructure in precision medicine with a vision to implement precision medicine into clinical settings and strengthen the collaboration between Swedish healthcare, research and life-science industry. GMS is comprised of seven regions with university hospitals and universities with a medical faculty. Together with patient organizations, healthcare providers, universities and industry, GMS aims to translate genomic innovation, based on advanced next-generation sequencing technologies, enabling greater precision in the diagnosis, treatment and management of patients with rare disease, cancer and infectious diseases.

Follow us

© Genomic Medicine Sweden - Alla rättigheter förbehållna